News

Fri, 25/05/2018
SFB/CRC-TR 128 retreat in Munich
Munich. The CRC-TR 128 “Multiple Sclerosis” corsially invites all its members – principal investigators as well as associated scientists and young investigators – to meet for a general scientific update, discussion and exchange at this year’s retreat. In addition to the PI meeting there will be a one-day conference especially for young investigators. When?: Thursday […]...more
Tue, 10/04/2018
Lecture: Environmental influence on the immune system
Mainz. The Research Center for Immunotherapy (FZI) and CRC 1292 are happy to welcome SFB 128 PI Prof. Karin Loser, MD, as a guest lecturer at their immunological seminar. Prof. Loser will talk about “Control of Immune responses by the environment”. When?: Thursday, April 26, 5:00 PM Where? University Medical Center Mainz, building 708, seminar […]...more
Fri, 16/03/2018
Lecture on Cell Interactions at the Blood-Brain-barrier
Muenster. The DFG-funded Comprehensive Research Centre “Breaking Barriers” cordially invites everyone interested in neuroimmunology to its upcoming Jour-Fixe Meeting where Luisa Klotz and Heinz Wiendl – both acting as PIs in the DFG-funded CRC “Multiple Sclerosis” (128) as well as “Breaking Barriers” (1009) – will hold a lecture on “Immune Cell Interactions with Endothelial Cells […]...more


Fri, 26/09/2014 | CRC Young Researchers win prizes at prestigious conferences

Congratulations to Dr. Nicholas Schwab and Dr. Tilman Schneider-Hohendorf, both from the Department of Neurology, University of Münster, who received prizes at two prestigious conferences recently!

Nicholas won the MSIF Young Researchers Award for the best presentation of a translational project by a young researcher at the annual congress of the European Committee for Treatment and Research into Multiple Sclerosis (ECTRIMS), which was held jointly with its American counterpart (ACTRIMS) in Boston in September.

Tilman won the Research Prize awarded by the Eva and Helmer Lehmann Foundation at the German Neurological Society conference, also in September, recognizing his recent contribution in the Journal of Experimental Medicine. More information about Tilman’s achievement can be found here (in German).

 

Well done to both of you!